Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record for a randomized Phase II trial of immunotherapy with or without radiotherapy in metastatic genitourinary cancers is displayed, including eligibility criteria, treatment arms, outcomes, and study dates.
    Difference
    54%
    Check dated 2026-11-07T14:39:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0; the page content remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T15:36:45.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about website updates and terminology appears above the study record page’s 403 error.
    Difference
    1%
    Check dated 2026-10-24T14:40:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:30:30.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:38:54.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content. This prevents access to the ClinicalTrials.gov record for the NCT03115801 study, hindering users from viewing details.
    Difference
    19%
    Check dated 2026-09-19T18:36:56.000Z thumbnail image

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.